Prasol Chemicals IPO Analysis: Should You Apply? GMP, Review & Details

Prasol Chemicals is a MAINBOARD IPO in the Specialty Chemicals sector. The issue price band is ₹643.0–₹676.0 per share. Issue size is ₹500.0 crore. Current GMP is -1.92% over the issue price (unofficial, subject to change).

Prasol Chemicals IPO — Key Details

Company Overview

Prasol Chemicals operates in the specialty chemicals sector, manufacturing over 150 specialty chemicals including acetone-based, phosphorous-based, and other complex chemicals. The company serves five major industries: performance chemicals, pharmaceuticals, agrochemicals, paint and inks, and home and personal care. With two manufacturing facilities in Khopoli and Mahad, Prasol has an aggregate capacity of 87,914 MT per year and a strong global distribution network, serving 1,107 customers in 69 countries.

Financial Performance

Total income was ₹887.56 Cr in the year ended 31 Mar 2024, rising to ₹1,015.54 Cr by 31 Mar 2025, and further increasing to ₹1,237.85 Cr in the year ended 31 Mar 2026. Profit After Tax increased from ₹18.13 Cr for the year ended 31 Mar 2024 to ₹43.57 Cr by 31 Mar 2025, and further to ₹83.12 Cr in the year ended 31 Mar 2026.

Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: 1. Repayment and/or pre-payment of certain borrowings amounting to ₹60.00 Cr. 2. General Corporate Purposes amounting to ₹16.39 Cr. 3. Issue Expenses amounting to ₹21.95 Cr. Totaling ₹98.34 Cr.

Strengths & Weaknesses

Strengths

Prasol Chemicals has a highly diversified product portfolio, established R&D capabilities, long-standing customer relationships, and a strong global presence.

Understanding Grey Market Premium (GMP)

The Grey Market Premium (GMP) is an unofficial indicator of how much a stock might list above or below its issue price. A positive GMP suggests strong demand, while a negative GMP indicates weaker demand. Investors should consider GMP as one of many factors when evaluating an IPO.

Subscription Status

As of 10th Sep 2026, the IPO was subscribed 3.47 times overall. The Institutional category saw the highest demand at 7.59 times, while the Retail category was subscribed 1.79 times.

Peer Comparison

• Excel Industries Ltd: NAV ₹1354.74, RoNW 4.44%, P/E 17.12
• Yasho Industries Ltd: NAV ₹368.18, RoNW 5.69%, P/E 206.68
• Privi Speciality Chemicals Ltd: NAV ₹368.79, RoNW 21.99%, P/E 42.67
• Vinati Organic Ltd: NAV ₹304.99, RoNW 14.03%, P/E 30.95
• Laxmi Organic Industries Ltd: NAV ₹71.66, RoNW 4%, P/E 59.74
• Atul Ltd: NAV ₹2136.46, RoNW 10.95%, P/E 28.04
• Aarti Industries Ltd: NAV ₹164.27, RoNW 7.04%, P/E 46.75

IPO Timeline

The IPO process includes several key dates: the opening date for subscription is 8th September 2026, closing on 10th September 2026. Allotment of shares will be done on 11th September 2026, and the listing date on the stock exchange is set for 16th September 2026.

Should You Apply for Prasol Chemicals IPO?

Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. It's important to consider the company's fundamentals and market conditions.

Investors who prefer stable, low-risk investments or those who are not comfortable with the potential for short-term price fluctuations may want to avoid investing in IPOs, which can be more volatile.

This is general risk-profile education, not a personal recommendation to apply or avoid this specific IPO — TopFund is not a SEBI-registered investment adviser.

Listing Day Risks

Investors should be aware that listing gains are not guaranteed. Factors such as market conditions and investor sentiment can significantly influence the stock price on the listing day. It is essential to consider these risks when investing in an IPO.

Trending Searches

Disclaimer: This is educational content, not investment advice. GMP is an unofficial grey-market indicator, unregulated and never guaranteed. TopFund is not a SEBI-registered investment adviser — please do your own research or consult a qualified adviser before applying to any IPO.